PF-AtlasClinical Trials › NCT02859194

The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation on Coronary Oxygenation in Lung Transplantation Patients

Veno-veno-arterial ECMO · Not specified

Registry ID
NCT02859194
Phase
Not specified
Status
Completed
Drug / intervention
Veno-veno-arterial ECMO
Sponsor
Yonsei University
Start
2016-05-31
Enrollment
10
Locations
1

About this trial

ECMO(Extracorporeal membrane oxygenation) is being essential for cardiopulmonary failure patients. There are two types of ECMO, which is veno-veno (V-V) that can be used in respiratory failure patients and veno-arterial (V-A) that can be used in cardiac failure patients. V-A ECMO can also be used during lung transplantation, substitution of cardiopulmonary bypass, which can show sufficient performance during operation and better postoperative outcome. However, regarding V-A ECMO circulating from femoral vein to femoral artery, there is a pro blem of differential hypoxia which might influence coronary artery and head vessels. In this prospective study, the investigators are planning to put another ECMO catheter into internal jugular vein which takes a role of left to right shunt, to mitigate the hypoxia of coronary artery.

View NCT02859194 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT02859194 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.